Investor Relations

We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery technology.

Lipocine to Present at the Oppenheimer 28th Annual Healthcare Conference
 Wednesday, March 21, 2018
 3:55pm - 4:55pm EDT